Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-11

FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a Supplemental Application for omeprazole by Sandoz Inc, confirming approval of a supplement to the Abbreviated New Drug Application (ANDA). This a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)